2001
Serum complement activation in congestive heart failure
Clark D, Cleman M, Pfau S, Rollins S, Ramahi T, Mayer C, Caulin-Glaser T, Daher E, Kosiborod M, Bell L, Setaro J. Serum complement activation in congestive heart failure. American Heart Journal 2001, 141: 684-690. PMID: 11275938, DOI: 10.1067/mhj.2001.113758.Peer-Reviewed Original ResearchConceptsCongestive heart failureSymptomatic heart failureC5b-9 levelsHeart failureClinical outcomesC5b-9Control patientsNew York Heart Association class IV symptomsComplement activationAge-matched control patientsClass IV symptomsCombined clinical outcomeAdverse clinical outcomesVentricular ejection fractionTerminal complement complex C5b-9Terminal complement activationComplement complex C5b-9Serum complement activationTerminal complement complexAdverse eventsCardiopulmonary bypassEjection fractionSerum levelsMyocardial injuryMyocardial infarction
1995
720-3 Predictors for Adverse Clinical Events are Different in Stents and PTCA: Results from the STent REStenosis Study
Wong S, Chuang Y, Schatz R, Baim D, Goldberg S, Cleman M, Brinker J, Bailey S, Leon M. 720-3 Predictors for Adverse Clinical Events are Different in Stents and PTCA: Results from the STent REStenosis Study. Journal Of The American College Of Cardiology 1995, 25: 123a. DOI: 10.1016/0735-1097(95)91964-y.Peer-Reviewed Original ResearchMinimal lumen diameterAdverse clinical eventsStent Restenosis StudyFinal minimal lumen diameterClinical eventsAngiographic restenosisLate complicationsClinical outcomesRestenosis StudyAdverse clinical outcomesMultivariate logistic analysisPaucity of dataAdjunct PTCAPTCA treatmentAngiographic predictorsIndependent predictorsDiameter stenosisStent implantationAnatomic factorsProcedural failureProcedure failureLogistic analysisPT outcomesPTCAMultivariate analysis